myofasciitis

myofascial pain syndrome

A chronic, nonprogressive, nondegenerative and non-inflammatory musculoskeletal pain syndrome, which is characterised by local or referred pain evoked at multiple trigger points and accompanied by stiffness, weakness, “knot formation”, and decreased range of motion in precise, specific patterns.
 
Clinical findings
Generalised pain—head, neck, chest, joints, pelvis, back, sciatica.
 
Management
Three-step analgesic ladder: injection with local anaesthetics, steroids, anti-inflammatories.

Mechanism
Possibly autonomic dysfunction.

myofasciitis

(mī″ō-făs″ē-i′tĭs) [″ + L. fascia, band, + Gr. itis, inflammation]
Inflammation of a muscle and its fascia.
References in periodicals archive ?
Arthritis, type 1 diabetes, multiple sclerosis, lupus, macrophagic myofasciitis, and autism spectrum disorders are among the autoimmune/ inflammatory conditions linked to aluminum-adjuvanted vaccines.
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
Macrophagic myofasciitis was first reported by Gherardi et al in 1998.
Two years earlier, he had been diagnosed with macrophagic myofasciitis.
These vocal fold deposits have not been previously described in patients with macrophagic myofasciitis.
One-third of patients with macrophagic myofasciitis develop an autoimmune disease.
The etiology of macrophagic myofasciitis remained obscure until 2001.
The researchers call the condition macrophagic myofasciitis (MMF).
A June 2006 muscle biopsy revealed the presence of aluminum, confirming a diagnosis of macrophagic myofasciitis.
A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.